{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-037764","form_type":"8-K","ticker":"RVPH","cik":"0001742927","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2024-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.425829+00:00","generated_at":"2026-05-29T02:03:04.107408+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Reviva prices $18M public offering of 12M shares and warrants","bullets":["Offering of 12M shares of common stock plus Series A warrants (6M shares, 6-month term) and Series B warrants (12M shares, 5-year term) at $1.50/unit.","Gross proceeds $18M; net proceeds ~$15.8M after underwriting discounts and expenses.","Series A warrants exercisable at $1.50, expire in 6 months; Series B warrants at $1.50, expire in 5 years.","Expected closing on December 18, 2024; Citizens JMP Securities is sole bookrunner.","Proceeds to fund R&D, working capital, and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-037764","json":"https://secwatch.observer/filing/0001437749-24-037764.json","markdown":"https://secwatch.observer/filing/0001437749-24-037764.md","text":"https://secwatch.observer/filing/0001437749-24-037764.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774924037764/0001437749-24-037764-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774924037764/rvph20241217_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T02:03:04.107408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}